UZEDY (risperidone) extended-release injectable suspension is a prescription medicine used to treat schizophrenia in adults. For more information about UZEDY, see the full Prescribing Information, including Boxed WARNING, or talk to your healthcare provider.

Official HCP site. Review important information about UZEDY® (risperidone) extended-release injectable suspension, an FDA approved LAI for schizophrenia in adults. Please see full Prescribing Information, including Boxed WARNING for UZEDY.

Monthly and every-two months subcutaneous risperidone for treatment of schizophrenia, UZEDY is the first treatment based on BEPO® technology approved by the U.S. FDA. UZEDY has been distributed since May 2023 in the United States by Teva (BEPO® technology is licensed to Teva under the name SteadyTeq™).

2022年5月20日 · The mark consists of Half moon shape with light blue and purple dots and uppercase word UZEDY in dark blue. Pharmaceutical preparations for the prevention and …

View images of Uzedy and identify pills by imprint code, shape and color with the Drugs.com Pill Identifier.

2022年5月3日 · UZEDY is a trademark and brand of Teva Pharmaceuticals USA, Inc., Parsippany 07054, UNITED STATES. This trademark was filed to EUIPO on Monday, August 23, 2021.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally.

2023年7月12日 · Uzedy injection is an extended-release injectable suspension used in adults to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Uzedy belongs to a class of medications called atypical antipsychotics.

Based on TEVA PHARMACEUTICALS USA, Inc., the UZEDY trademark is used in the following business: Pharmaceutical preparations for the prevention and treatment of psychological disorders, namely, schizophrenia .

警告提示 Uzedy的产品标签上有一个针对患有痴呆相关精神病的老年患者增加死亡风险的 黑框警告。 它不被批准用于治疗老年痴呆相关精神病。